# Determining Reactogenicity and Immunogenicity of Delayed COVID-19 Vaccine Schedule in Children

> **NCT05329064** · PHASE4 · UNKNOWN · sponsor: **KK Women's and Children's Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Vaccine Reaction
- COVID-19
- Children, Only

## Interventions

- **BIOLOGICAL:** BNT162b2 Pfizer-BioNTech/Comirnaty

## Key facts

- **NCT ID:** NCT05329064
- **Lead sponsor:** KK Women's and Children's Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-24
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05329064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05329064, "Determining Reactogenicity and Immunogenicity of Delayed COVID-19 Vaccine Schedule in Children". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05329064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*